This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Diabetes, Metabolic Syndrome And Cardiovascular Disease

Table 6.1: Value Market Shares of Animal, Human and Modern Insulin, 1995-2010 101

Table 6.2: Worldwide Insulin Sales, 2008-2016 102

Table 6.3: Worldwide Insulin Sales and Market Share by World Region, 2011 102

Table 6.4: Estimated U.S. Retail Insulin Sales, 2011-2016 102

Table 6.5: Worldwide Insulin Sales and Market Share by Company, 2011 103

Table 6.6: U.S. Insulin Sales and Market Share by Company, 2011 103

Table 6.7: Insulins on the U.S. Market 105

Table 6.8: Pharmacokinetics of Therapeutic Insulins on the U.S. Market 106

Table 6.9: Pharmacokinetics of Short-Acting Insulins 108

Table 6.10: Pharmacokinetics of Rapid-Acting Insulins 108

Table 6.11: Pharmacokinetics of Intermediate-Acting Insulins 110

Table 6.12: Pharmacokinetics of Long-Acting Insulins 110

Table 6.13: Pharmacokinetics of Insulin Mixtures 112

Table 6.14: Status of Inhaled Insulin Products, 2011 117

Table 6.15: Key Drivers of the Type 2 Diabetes Insulin Market, 2012 122

Table 6.16: A Comparison of Existing Insulin Delivery Devices 123

Table 6.17: Insulin Pens 125

Table 6.18: Estimated Worldwide Demand for Insulin Injector Pens by Volume, 2012-2016 127

Table 6.19: Injection Aids 128

Table 6.20: Jet Injectors 130

Table 6.21: Control Averages by Treatment 131

Table 6.22: Reduced Risk for Various Diseases When Blood Glucose is Near Normal 131

Table 6.23: Leading Insulin Pump Manufacturers 132

Table 6.24: Comparison of Current External Insulin Pumps on the Market 132

Table 6.25: Insulin Infusion Sets 137

Table 6.26: Worldwide Insulin Pump Market, 2009-2016 141

Table 7.1: Advantages and Disadvantages of Newer Type 2 Diabetes Therapies 146

Table 7.2: Cells of the Pancreas 148

Table 7.3: Lipoprotein Risk Levels and Treatment Goals in Adult Patients with Diabetes 154

Table 7.4: Agents for Lowering Lipid Levels in Patients with Dyslipidemia 155

Table 7.5: Suggested Pharmacological Treatment Agents for Hypertension in Patients with Diabetes 156

Table 8.1: Criteria for the Diagnosis of Diabetes 159

8 of 9

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,943.81 +28.74 0.17%
S&P 500 1,967.57 +2.89 0.15%
NASDAQ 4,415.49 +19.2860 0.44%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs